Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decreased expression of autophagy-related genes in the complete remission phase of acute myeloid leukemia. | Mol Genet Genomic Med | 2022 | 35128828 | PubTator, text mining | PubMed |
| Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia. | Leukemia | 2022 | 35121847 | PubTator, text mining | PubMed |
| Epigenetic therapy with chidamide alone or combined with 5‑azacitidine exerts antitumour effects on acute myeloid leukaemia cells in vitro. | Oncol Rep | 2022 | 35103292 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing to track novel perspectives in HSC heterogeneity. | Stem Cell Res Ther | 2022 | 35093185 | PubTator, text mining | PubMed |
| LncSIK1 enhanced the sensitivity of AML cells to retinoic acid by the E2F1/autophagy pathway. | Cell Prolif | 2022 | 35092119 | PubTator, text mining | PubMed |
| Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study. | Clin Interv Aging | 2022 | 35082491 | PubTator, text mining | PubMed |
| RUNX3 overexpression inhibits normal human erythroid development. | Sci Rep | 2022 | 35075235 | PubTator, text mining | PubMed |
| A 29-gene signature associated with NOX2 discriminates acute myeloid leukemia prognosis and survival. | Am J Hematol | 2022 | 35073432 | PubTator, text mining | PubMed |
| Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia. | Cancer J | 2022 | 35072377 | PubTator, text mining | PubMed |
| Evolution of Therapy for Older Patients With Acute Myeloid Leukemia: How Should We Use Currently Available Agents? | Cancer J | 2022 | 35072376 | PubTator, text mining | PubMed |
| Comparison between Heat-Clearing Medicine and Antirheumatic Medicine in Treatment of Gastric Cancer Based on Network Pharmacology, Molecular Docking, and Tumor Immune Infiltration Analysis. | Evid Based Complement Alternat Med | 2022 | 35069767 | PubTator, text mining | PubMed |
| Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies. | J Hematol Oncol | 2022 | 35065680 | PubTator, text mining | PubMed |
| The Action of Vitamin D in Adipose Tissue: Is There the Link between Vitamin D Deficiency and Adipose Tissue-Related Metabolic Disorders? | Int J Mol Sci | 2022 | 35055140 | PubTator, text mining | PubMed |
| The Role of N6-Methyladenosine (m6A) Methylation Modifications in Hematological Malignancies. | Cancers (Basel) | 2022 | 35053496 | PubTator, text mining | PubMed |
| Super-Enhancers Dysregulations in Hematological Malignancies. | Cells | 2022 | 35053311 | PubTator, text mining | PubMed |
| Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML. | Ann Hematol | 2022 | 35024892 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Tripterine Anti-Ovarian Cancer Effects Using Weighted Gene Co-Expression Network Analysis and Molecular Docking. | Med Sci Monit | 2022 | 35022380 | PubTator, text mining | PubMed |
| Development and measurement properties of the AxEL (attitude toward education and advice for low-back-pain) questionnaire. | Health Qual Life Outcomes | 2022 | 35012565 | PubTator, text mining | PubMed |
| Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives. | J Clin Med | 2022 | 35011994 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation analysis in pediatric acute myeloid leukemia. | Blood Adv | 2022 | 35008106 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=43